During the past decade, Wakayama Medical University conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wakayama Medical University" #1 sponsor was "Wakayama Medical University" with 10 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Assiut University" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wakayama Medical University" #1 collaborator was "Wakayama Medical University" with 4 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Aichi Medical University" with 1 trials as a collaborator and "Ajou University School of Medicine" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Wakayama Medical University" are "Coronary Artery Disease" (5 trials), "Acute Coronary Syndrome" (2 trials), "Atherosclerosis" (2 trials), "Coronary Stenosis" (2 trials) and "Pancreatic Cancer" (2 trials). Many other conditions were trialed in "Wakayama Medical University" in a lesser frequency.

Most popular intervention types in "Wakayama Medical University" are "Drug" (10 trials), "Device" (7 trials), "Procedure" (5 trials), "Diagnostic Test" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "5% Dextrose Solution" (1 trials), "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials) and "Angiotensin Receptor Blockers" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wakayama Medical University" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Wakayama Medical University". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Wakayama Medical University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wakayama Medical University, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Wakayama Medical University has several departments that took part in Clinical trials: "Second Department of Surgery, Wakayama Medical University" - 9 trials